Savolitinib (Orpathys®) or Savolitinib API / Volitinib
Product sourcing details
Buy Savolitinib (Orpathys®) API / Volitinib, a selective MET tyrosine kinase inhibitor (CAS 1313725-88-0). High purity (typically ≥98% HPLC), white to off-white powder, available in customizable quantities (1g to kg). For research and development of anticancer therapies, including MET exon 14 skipping-altered NSCLC. COA/MSDS available. Cool, dry storage recommended.
Minimum Order
1
Packaging
N/A
Delivery
15 Days
Specifications
CAS Number: 1313725-88-0
Chemical Name / IUPAC: (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine
Molecular Formula: C₁₇H₁₅N₉
Molecular Weight: 345.36 g/mol
Category: Anticancer / Antineoplastic API; selective MET tyrosine kinase inhibitor
Indication/Use: Treatment of MET exon 14 skipping-altered non-small cell lung cancer (NSCLC); marketed as Orpathys® in China (conditional approval); under development globally by AstraZeneca and HUTCHMED
Purity/Assay: Typically ≥98% (HPLC) for API grade; specify your batch (e.g., 98.44% or higher)
Appearance: Usually white to off-white powder
Package: e.g., 1g, 5g, 10g, 100g, 1kg, or bulk (customizable)
Storage: Sealed, cool, dry place; protect from light
Other Specs: Solubility (e.g., in DMSO), stability data, GMP/CEP status if applicable, manufacturer certifications, COA/MSDS availability
